EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Ambroxol displaces α-synuclein from the membrane and inhibits the formation of early protein–lipid coaggregates

Jesper E Dreier, Alisdair Stevenson, Elliot Carles, Katharina Schott, Thomas C T Michaels iD, Céline Galvagnion iD

Chemical Science · 2026 · 17 (1) · 354-363

DOI: 10.1039/d5sc06116d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Science, 2026. Verfasst von Jesper E Dreier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen 2100 Copenhagen Denmark celine.galvagnio…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Eidgenössische Technische Hochschule Zürich, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Novo Nordisk Fonden.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ambroxol, a small molecule known to stabilise Glucocerebrosidase, can act directly on α-synuclein–lipid coaggregation into amyloid fibrils, a process associated with Parkinson's disease, by preventing the formation of early protein–lipid oligomers.

Autor:innen und Institutionen

  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen 2100 Copenhagen Denmark celine.galvagnion@sund.ku.dk.
  • Department of Biology, Institute of Biochemistry, ETH Zurich Otto Stern Weg 3 8093 Zurich Switzerland thomas.michaels@bc.biol.ethz.ch.
  • Bringing Materials to Life (BML) Initiative, ETH Zurich Switzerland.

ORCID-Profile: Thomas C T Michaels, Céline Galvagnion

Förderung

  • Eidgenössische Technische Hochschule Zürich
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Novo Nordisk Fonden
  • Danmarks Frie Forskningsfond

Zitieren

APA

Dreier, J. E., Stevenson, A., Carles, E., Schott, K., Michaels, T. C. T., & Galvagnion, C. (2026). Ambroxol displaces α-synuclein from the membrane and inhibits the formation of early protein–lipid coaggregates. Chemical Science, 17(1), 354-363. https://doi.org/10.1039/d5sc06116d

Vancouver

Dreier JE, Stevenson A, Carles E, Schott K, Michaels TCT, Galvagnion C. Ambroxol displaces α-synuclein from the membrane and inhibits the formation of early protein–lipid coaggregates. Chemical Science. 2026;17(1):354-363. doi:10.1039/d5sc06116d

BibTeX
@article{Dreier2026,
  author = {Dreier, Jesper E and Stevenson, Alisdair and Carles, Elliot and Schott, Katharina and Michaels, Thomas C T and Galvagnion, Céline},
  title = {Ambroxol displaces α-synuclein from the membrane and inhibits the formation of early protein–lipid coaggregates},
  journal = {Chemical Science},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {354--363},
  doi = {10.1039/d5sc06116d}
}
Kostenlos starten →